The present invention comprises an amount of lysophosphatidylglycerol suitable for oral administration effective to reduce or prevent one or more cardiac channel diseases or conditions due to irregularities or alterations in the heart pattern caused by the active agent or drug. Compositions and methods for preventing one or more cardiac channel diseases or conditions due to irregularities or alterations in the heart pattern caused by an active agent or drug in a subject.
展开▼
